FDA approves first pill to treat all forms of hepatitis C

By Associated Press  |  June 28, 2016

Federal health officials have approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus.

CMS defends Medicare Part B proposal

CMS defends Medicare Part B proposal

By Shannon Muchmore  |  June 28, 2016

The proposal to change the way doctors are reimbursed for prescribing outpatient drugs has been criticized by lawmakers of both parties and by multiple patient and doctor groups.

Harvard Pilgrim scores discounts on Novartis, Lilly drugs

By Erica Teichert  |  June 28, 2016

Harvard Pilgrim will receive discounts on Novartis' congestive heart failure drug Entresto if the drug doesn't reach an agreed-upon reduction in hospitalizations. Under the Lilly agreement, Harvard Pilgrim has made the drugmaker's type 2 diabetes drug Trulicity a preferred drug in exchange for a...

Editorial: Medicare Part B drug proposal deserves support

Editorial: Medicare Part B drug proposal deserves support

By Merrill Goozner  |  June 25, 2016

Medicare's first step in reining in the skyrocketing cost of specialty drugs deserves support—something it has not received from hospitals, doctors, politicians or, of course, the pharmaceutical industry, which benefits the most from the status quo.

Rx pizza: 1 free meal can sway doctor prescribing

By Associated Press  |  June 21, 2016

As little as one free meal from a drug company can influence which medicines doctors prescribe for Medicare patients, according to a study using Medicare records and recently released data from the healthcare law's Open Payments program.

Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.